Collegium Pharmaceutical Inc completed a $20 million Series D round of funding led by Frazier Healthcare Ventures. Previous investors Boston Millennia Partners and Westfield Capital Management participated. Company Web site
Return to search
![]()
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.